Global Phage Therapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Phage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Phage Therapy is forecast to a readjusted size of US$ 101.3 million by 2030 with a CAGR of 18.3% during review period.
The research report highlights the growth potential of the global Phage Therapy market. Phage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Phage Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Phage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Key Features:
The report on Phage Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Phage Therapy market. It may include historical data, market segmentation by Type (e.g., DsDNA Bacteriophage, SsDNA Bacteriophage), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Phage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Phage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Phage Therapy industry. This include advancements in Phage Therapy technology, Phage Therapy new entrants, Phage Therapy new investment, and other innovations that are shaping the future of Phage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Phage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Phage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Phage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Phage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Phage Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Phage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Phage Therapy market.
Market Segmentation:
Phage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Phage Therapy market size was valued at US$ 31 million in 2023. With growing demand in downstream market, the Phage Therapy is forecast to a readjusted size of US$ 101.3 million by 2030 with a CAGR of 18.3% during review period.
The research report highlights the growth potential of the global Phage Therapy market. Phage Therapy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Phage Therapy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Phage Therapy market.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%.
Key Features:
The report on Phage Therapy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Phage Therapy market. It may include historical data, market segmentation by Type (e.g., DsDNA Bacteriophage, SsDNA Bacteriophage), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Phage Therapy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Phage Therapy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Phage Therapy industry. This include advancements in Phage Therapy technology, Phage Therapy new entrants, Phage Therapy new investment, and other innovations that are shaping the future of Phage Therapy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Phage Therapy market. It includes factors influencing customer ' purchasing decisions, preferences for Phage Therapy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Phage Therapy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Phage Therapy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Phage Therapy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Phage Therapy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Phage Therapy market.
Market Segmentation:
Phage Therapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- DsDNA Bacteriophage
- SsDNA Bacteriophage
- SsRNA Bacteriophage
- Others
- Animal Health
- Aquaculture
- Agriculture
- Food Industry
- Human Health
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- NPO Microgen
- Proteon Pharmaceuticals
- Phagelux
- Intralytix
- Micreos
- Eliava BioPreparations
- Locus Biosciences,Inc
- Pharmex Group,LLC
- Pherecydes Pharma
- APS Biocontrol Ltd. (APS)
- Qingdao Phagepharm Bio-tech
- Fixed-Phage Limited
- Zeptometrix
- Phage International, Inc.
- MicroMir
- iNtODEWORLD, Inc.
- NEXTBIOTICS
- Armata Pharmaceuticals, Inc.
- Innophage
- Adaptive Phage Therapeutics
- TechnoPhage
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phage Therapy Market Size 2019-2030
2.1.2 Phage Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy Market Size by Type
2.3.1 Phage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Phage Therapy Market Size Market Share by Type (2019-2024)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy Market Size by Application
2.5.1 Phage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Phage Therapy Market Size Market Share by Application (2019-2024)
3 PHAGE THERAPY MARKET SIZE BY PLAYER
3.1 Phage Therapy Market Size Market Share by Players
3.1.1 Global Phage Therapy Revenue by Players (2019-2024)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY BY REGIONS
4.1 Phage Therapy Market Size by Regions (2019-2024)
4.2 Americas Phage Therapy Market Size Growth (2019-2024)
4.3 APAC Phage Therapy Market Size Growth (2019-2024)
4.4 Europe Phage Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Phage Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Phage Therapy Market Size by Country (2019-2024)
5.2 Americas Phage Therapy Market Size by Type (2019-2024)
5.3 Americas Phage Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy Market Size by Region (2019-2024)
6.2 APAC Phage Therapy Market Size by Type (2019-2024)
6.3 APAC Phage Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Phage Therapy by Country (2019-2024)
7.2 Europe Phage Therapy Market Size by Type (2019-2024)
7.3 Europe Phage Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phage Therapy by Region (2019-2024)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHAGE THERAPY MARKET FORECAST
10.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2025-2030)
10.2.1 United States Phage Therapy Market Forecast
10.2.2 Canada Phage Therapy Market Forecast
10.2.3 Mexico Phage Therapy Market Forecast
10.2.4 Brazil Phage Therapy Market Forecast
10.3 APAC Phage Therapy Forecast by Region (2025-2030)
10.3.1 China Phage Therapy Market Forecast
10.3.2 Japan Phage Therapy Market Forecast
10.3.3 Korea Phage Therapy Market Forecast
10.3.4 Southeast Asia Phage Therapy Market Forecast
10.3.5 India Phage Therapy Market Forecast
10.3.6 Australia Phage Therapy Market Forecast
10.4 Europe Phage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Phage Therapy Market Forecast
10.4.2 France Phage Therapy Market Forecast
10.4.3 UK Phage Therapy Market Forecast
10.4.4 Italy Phage Therapy Market Forecast
10.4.5 Russia Phage Therapy Market Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Phage Therapy Market Forecast
10.5.2 South Africa Phage Therapy Market Forecast
10.5.3 Israel Phage Therapy Market Forecast
10.5.4 Turkey Phage Therapy Market Forecast
10.5.5 GCC Countries Phage Therapy Market Forecast
10.6 Global Phage Therapy Forecast by Type (2025-2030)
10.7 Global Phage Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Phage Therapy Market Size 2019-2030
2.1.2 Phage Therapy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 SsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy Market Size by Type
2.3.1 Phage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Phage Therapy Market Size Market Share by Type (2019-2024)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy Market Size by Application
2.5.1 Phage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Phage Therapy Market Size Market Share by Application (2019-2024)
3 PHAGE THERAPY MARKET SIZE BY PLAYER
3.1 Phage Therapy Market Size Market Share by Players
3.1.1 Global Phage Therapy Revenue by Players (2019-2024)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PHAGE THERAPY BY REGIONS
4.1 Phage Therapy Market Size by Regions (2019-2024)
4.2 Americas Phage Therapy Market Size Growth (2019-2024)
4.3 APAC Phage Therapy Market Size Growth (2019-2024)
4.4 Europe Phage Therapy Market Size Growth (2019-2024)
4.5 Middle East & Africa Phage Therapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Phage Therapy Market Size by Country (2019-2024)
5.2 Americas Phage Therapy Market Size by Type (2019-2024)
5.3 Americas Phage Therapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Phage Therapy Market Size by Region (2019-2024)
6.2 APAC Phage Therapy Market Size by Type (2019-2024)
6.3 APAC Phage Therapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Phage Therapy by Country (2019-2024)
7.2 Europe Phage Therapy Market Size by Type (2019-2024)
7.3 Europe Phage Therapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Phage Therapy by Region (2019-2024)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2019-2024)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PHAGE THERAPY MARKET FORECAST
10.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.1 Global Phage Therapy Forecast by Regions (2025-2030)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Country (2025-2030)
10.2.1 United States Phage Therapy Market Forecast
10.2.2 Canada Phage Therapy Market Forecast
10.2.3 Mexico Phage Therapy Market Forecast
10.2.4 Brazil Phage Therapy Market Forecast
10.3 APAC Phage Therapy Forecast by Region (2025-2030)
10.3.1 China Phage Therapy Market Forecast
10.3.2 Japan Phage Therapy Market Forecast
10.3.3 Korea Phage Therapy Market Forecast
10.3.4 Southeast Asia Phage Therapy Market Forecast
10.3.5 India Phage Therapy Market Forecast
10.3.6 Australia Phage Therapy Market Forecast
10.4 Europe Phage Therapy Forecast by Country (2025-2030)
10.4.1 Germany Phage Therapy Market Forecast
10.4.2 France Phage Therapy Market Forecast
10.4.3 UK Phage Therapy Market Forecast
10.4.4 Italy Phage Therapy Market Forecast
10.4.5 Russia Phage Therapy Market Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2025-2030)
10.5.1 Egypt Phage Therapy Market Forecast
10.5.2 South Africa Phage Therapy Market Forecast
10.5.3 Israel Phage Therapy Market Forecast
10.5.4 Turkey Phage Therapy Market Forecast
10.5.5 GCC Countries Phage Therapy Market Forecast
10.6 Global Phage Therapy Forecast by Type (2025-2030)
10.7 Global Phage Therapy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11.11 Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Phage Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of DsDNA Bacteriophage
Table 3. Major Players of SsDNA Bacteriophage
Table 4. Major Players of SsRNA Bacteriophage
Table 5. Major Players of Others
Table 6. Phage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Phage Therapy Market Size Market Share by Type (2019-2024)
Table 9. Phage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Phage Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Phage Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Phage Therapy Revenue Market Share by Player (2019-2024)
Table 14. Phage Therapy Key Players Head office and Products Offered
Table 15. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phage Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Phage Therapy Market Size Market Share by Regions (2019-2024)
Table 20. Global Phage Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Phage Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Phage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Phage Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Phage Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Phage Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Phage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Phage Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Phage Therapy Market Size Market Share by Type (2019-2024)
Table 32. APAC Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Phage Therapy Market Size Market Share by Application (2019-2024)
Table 34. Europe Phage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Phage Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Phage Therapy Market Size Market Share by Type (2019-2024)
Table 38. Europe Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Phage Therapy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Phage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Phage Therapy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Phage Therapy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Phage Therapy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Phage Therapy
Table 47. Key Market Challenges & Risks of Phage Therapy
Table 48. Key Industry Trends of Phage Therapy
Table 49. Global Phage Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Phage Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Phage Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Phage Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 54. NPO Microgen Phage Therapy Product Offered
Table 55. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. NPO Microgen Main Business
Table 57. NPO Microgen Latest Developments
Table 58. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 59. Proteon Pharmaceuticals Phage Therapy Product Offered
Table 60. Proteon Pharmaceuticals Main Business
Table 61. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Proteon Pharmaceuticals Latest Developments
Table 63. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 64. Phagelux Phage Therapy Product Offered
Table 65. Phagelux Main Business
Table 66. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Phagelux Latest Developments
Table 68. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 69. Intralytix Phage Therapy Product Offered
Table 70. Intralytix Main Business
Table 71. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Intralytix Latest Developments
Table 73. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 74. Micreos Phage Therapy Product Offered
Table 75. Micreos Main Business
Table 76. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Micreos Latest Developments
Table 78. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 79. Eliava BioPreparations Phage Therapy Product Offered
Table 80. Eliava BioPreparations Main Business
Table 81. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Eliava BioPreparations Latest Developments
Table 83. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 84. Locus Biosciences,Inc Phage Therapy Product Offered
Table 85. Locus Biosciences,Inc Main Business
Table 86. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Locus Biosciences,Inc Latest Developments
Table 88. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 89. Pharmex Group,LLC Phage Therapy Product Offered
Table 90. Pharmex Group,LLC Main Business
Table 91. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Pharmex Group,LLC Latest Developments
Table 93. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 94. Pherecydes Pharma Phage Therapy Product Offered
Table 95. Pherecydes Pharma Main Business
Table 96. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Pherecydes Pharma Latest Developments
Table 98. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 99. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
Table 100. APS Biocontrol Ltd. (APS) Main Business
Table 101. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. APS Biocontrol Ltd. (APS) Latest Developments
Table 103. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 104. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
Table 105. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Qingdao Phagepharm Bio-tech Main Business
Table 107. Qingdao Phagepharm Bio-tech Latest Developments
Table 108. Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 109. Fixed-Phage Limited Phage Therapy Product Offered
Table 110. Fixed-Phage Limited Main Business
Table 111. Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Fixed-Phage Limited Latest Developments
Table 113. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 114. Zeptometrix Phage Therapy Product Offered
Table 115. Zeptometrix Main Business
Table 116. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Zeptometrix Latest Developments
Table 118. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 119. Phage International, Inc. Phage Therapy Product Offered
Table 120. Phage International, Inc. Main Business
Table 121. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Phage International, Inc. Latest Developments
Table 123. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 124. MicroMir Phage Therapy Product Offered
Table 125. MicroMir Main Business
Table 126. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. MicroMir Latest Developments
Table 128. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 129. iNtODEWORLD, Inc. Phage Therapy Product Offered
Table 130. iNtODEWORLD, Inc. Main Business
Table 131. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. iNtODEWORLD, Inc. Latest Developments
Table 133. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 134. NEXTBIOTICS Phage Therapy Product Offered
Table 135. NEXTBIOTICS Main Business
Table 136. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. NEXTBIOTICS Latest Developments
Table 138. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 139. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
Table 140. Armata Pharmaceuticals, Inc. Main Business
Table 141. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Armata Pharmaceuticals, Inc. Latest Developments
Table 143. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 144. Innophage Phage Therapy Product Offered
Table 145. Innophage Main Business
Table 146. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Innophage Latest Developments
Table 148. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 149. Adaptive Phage Therapeutics Phage Therapy Product Offered
Table 150. Adaptive Phage Therapeutics Main Business
Table 151. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Adaptive Phage Therapeutics Latest Developments
Table 153. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 154. TechnoPhage Phage Therapy Product Offered
Table 155. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. TechnoPhage Main Business
Table 157. TechnoPhage Latest Developments
Table 1. Phage Therapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of DsDNA Bacteriophage
Table 3. Major Players of SsDNA Bacteriophage
Table 4. Major Players of SsRNA Bacteriophage
Table 5. Major Players of Others
Table 6. Phage Therapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Phage Therapy Market Size Market Share by Type (2019-2024)
Table 9. Phage Therapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Phage Therapy Market Size Market Share by Application (2019-2024)
Table 12. Global Phage Therapy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Phage Therapy Revenue Market Share by Player (2019-2024)
Table 14. Phage Therapy Key Players Head office and Products Offered
Table 15. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phage Therapy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Phage Therapy Market Size Market Share by Regions (2019-2024)
Table 20. Global Phage Therapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Phage Therapy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Phage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Phage Therapy Market Size Market Share by Country (2019-2024)
Table 24. Americas Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Phage Therapy Market Size Market Share by Type (2019-2024)
Table 26. Americas Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Phage Therapy Market Size Market Share by Application (2019-2024)
Table 28. APAC Phage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Phage Therapy Market Size Market Share by Region (2019-2024)
Table 30. APAC Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Phage Therapy Market Size Market Share by Type (2019-2024)
Table 32. APAC Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Phage Therapy Market Size Market Share by Application (2019-2024)
Table 34. Europe Phage Therapy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Phage Therapy Market Size Market Share by Country (2019-2024)
Table 36. Europe Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Phage Therapy Market Size Market Share by Type (2019-2024)
Table 38. Europe Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Phage Therapy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Phage Therapy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Phage Therapy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Phage Therapy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Phage Therapy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Phage Therapy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Phage Therapy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Phage Therapy
Table 47. Key Market Challenges & Risks of Phage Therapy
Table 48. Key Industry Trends of Phage Therapy
Table 49. Global Phage Therapy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Phage Therapy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Phage Therapy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Phage Therapy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 54. NPO Microgen Phage Therapy Product Offered
Table 55. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. NPO Microgen Main Business
Table 57. NPO Microgen Latest Developments
Table 58. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 59. Proteon Pharmaceuticals Phage Therapy Product Offered
Table 60. Proteon Pharmaceuticals Main Business
Table 61. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Proteon Pharmaceuticals Latest Developments
Table 63. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 64. Phagelux Phage Therapy Product Offered
Table 65. Phagelux Main Business
Table 66. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Phagelux Latest Developments
Table 68. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 69. Intralytix Phage Therapy Product Offered
Table 70. Intralytix Main Business
Table 71. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Intralytix Latest Developments
Table 73. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 74. Micreos Phage Therapy Product Offered
Table 75. Micreos Main Business
Table 76. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Micreos Latest Developments
Table 78. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 79. Eliava BioPreparations Phage Therapy Product Offered
Table 80. Eliava BioPreparations Main Business
Table 81. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Eliava BioPreparations Latest Developments
Table 83. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 84. Locus Biosciences,Inc Phage Therapy Product Offered
Table 85. Locus Biosciences,Inc Main Business
Table 86. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Locus Biosciences,Inc Latest Developments
Table 88. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 89. Pharmex Group,LLC Phage Therapy Product Offered
Table 90. Pharmex Group,LLC Main Business
Table 91. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Pharmex Group,LLC Latest Developments
Table 93. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 94. Pherecydes Pharma Phage Therapy Product Offered
Table 95. Pherecydes Pharma Main Business
Table 96. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Pherecydes Pharma Latest Developments
Table 98. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 99. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
Table 100. APS Biocontrol Ltd. (APS) Main Business
Table 101. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. APS Biocontrol Ltd. (APS) Latest Developments
Table 103. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 104. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
Table 105. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Qingdao Phagepharm Bio-tech Main Business
Table 107. Qingdao Phagepharm Bio-tech Latest Developments
Table 108. Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 109. Fixed-Phage Limited Phage Therapy Product Offered
Table 110. Fixed-Phage Limited Main Business
Table 111. Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Fixed-Phage Limited Latest Developments
Table 113. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 114. Zeptometrix Phage Therapy Product Offered
Table 115. Zeptometrix Main Business
Table 116. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Zeptometrix Latest Developments
Table 118. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 119. Phage International, Inc. Phage Therapy Product Offered
Table 120. Phage International, Inc. Main Business
Table 121. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Phage International, Inc. Latest Developments
Table 123. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 124. MicroMir Phage Therapy Product Offered
Table 125. MicroMir Main Business
Table 126. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. MicroMir Latest Developments
Table 128. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 129. iNtODEWORLD, Inc. Phage Therapy Product Offered
Table 130. iNtODEWORLD, Inc. Main Business
Table 131. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. iNtODEWORLD, Inc. Latest Developments
Table 133. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 134. NEXTBIOTICS Phage Therapy Product Offered
Table 135. NEXTBIOTICS Main Business
Table 136. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. NEXTBIOTICS Latest Developments
Table 138. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 139. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
Table 140. Armata Pharmaceuticals, Inc. Main Business
Table 141. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Armata Pharmaceuticals, Inc. Latest Developments
Table 143. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 144. Innophage Phage Therapy Product Offered
Table 145. Innophage Main Business
Table 146. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Innophage Latest Developments
Table 148. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 149. Adaptive Phage Therapeutics Phage Therapy Product Offered
Table 150. Adaptive Phage Therapeutics Main Business
Table 151. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Adaptive Phage Therapeutics Latest Developments
Table 153. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 154. TechnoPhage Phage Therapy Product Offered
Table 155. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. TechnoPhage Main Business
Table 157. TechnoPhage Latest Developments
LIST OF FIGURES
Figure 1. Phage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phage Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Phage Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Phage Therapy Sales Market Share by Country/Region (2023)
Figure 8. Phage Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Phage Therapy Market Size Market Share by Type in 2023
Figure 10. Phage Therapy in Animal Health
Figure 11. Global Phage Therapy Market: Animal Health (2019-2024) & ($ Millions)
Figure 12. Phage Therapy in Aquaculture
Figure 13. Global Phage Therapy Market: Aquaculture (2019-2024) & ($ Millions)
Figure 14. Phage Therapy in Agriculture
Figure 15. Global Phage Therapy Market: Agriculture (2019-2024) & ($ Millions)
Figure 16. Phage Therapy in Food Industry
Figure 17. Global Phage Therapy Market: Food Industry (2019-2024) & ($ Millions)
Figure 18. Phage Therapy in Human Health
Figure 19. Global Phage Therapy Market: Human Health (2019-2024) & ($ Millions)
Figure 20. Phage Therapy in Others
Figure 21. Global Phage Therapy Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Phage Therapy Market Size Market Share by Application in 2023
Figure 23. Global Phage Therapy Revenue Market Share by Player in 2023
Figure 24. Global Phage Therapy Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 26. APAC Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 27. Europe Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 29. Americas Phage Therapy Value Market Share by Country in 2023
Figure 30. United States Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Phage Therapy Market Size Market Share by Region in 2023
Figure 35. APAC Phage Therapy Market Size Market Share by Type in 2023
Figure 36. APAC Phage Therapy Market Size Market Share by Application in 2023
Figure 37. China Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Phage Therapy Market Size Market Share by Country in 2023
Figure 44. Europe Phage Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Europe Phage Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Germany Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Phage Therapy Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Phage Therapy Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 60. APAC Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Europe Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 63. United States Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Canada Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 67. China Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Japan Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Korea Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 71. India Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Australia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Germany Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 74. France Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 75. UK Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Italy Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Russia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Spain Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 81. Israel Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 84. Global Phage Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Phage Therapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Phage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phage Therapy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Phage Therapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Phage Therapy Sales Market Share by Country/Region (2023)
Figure 8. Phage Therapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Phage Therapy Market Size Market Share by Type in 2023
Figure 10. Phage Therapy in Animal Health
Figure 11. Global Phage Therapy Market: Animal Health (2019-2024) & ($ Millions)
Figure 12. Phage Therapy in Aquaculture
Figure 13. Global Phage Therapy Market: Aquaculture (2019-2024) & ($ Millions)
Figure 14. Phage Therapy in Agriculture
Figure 15. Global Phage Therapy Market: Agriculture (2019-2024) & ($ Millions)
Figure 16. Phage Therapy in Food Industry
Figure 17. Global Phage Therapy Market: Food Industry (2019-2024) & ($ Millions)
Figure 18. Phage Therapy in Human Health
Figure 19. Global Phage Therapy Market: Human Health (2019-2024) & ($ Millions)
Figure 20. Phage Therapy in Others
Figure 21. Global Phage Therapy Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Phage Therapy Market Size Market Share by Application in 2023
Figure 23. Global Phage Therapy Revenue Market Share by Player in 2023
Figure 24. Global Phage Therapy Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 26. APAC Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 27. Europe Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Phage Therapy Market Size 2019-2024 ($ Millions)
Figure 29. Americas Phage Therapy Value Market Share by Country in 2023
Figure 30. United States Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Phage Therapy Market Size Market Share by Region in 2023
Figure 35. APAC Phage Therapy Market Size Market Share by Type in 2023
Figure 36. APAC Phage Therapy Market Size Market Share by Application in 2023
Figure 37. China Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Phage Therapy Market Size Market Share by Country in 2023
Figure 44. Europe Phage Therapy Market Size Market Share by Type (2019-2024)
Figure 45. Europe Phage Therapy Market Size Market Share by Application (2019-2024)
Figure 46. Germany Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Phage Therapy Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Phage Therapy Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Phage Therapy Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 60. APAC Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 61. Europe Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 63. United States Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 64. Canada Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 67. China Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 68. Japan Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 69. Korea Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 71. India Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 72. Australia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 73. Germany Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 74. France Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 75. UK Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 76. Italy Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 77. Russia Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 78. Spain Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 81. Israel Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Phage Therapy Market Size 2025-2030 ($ Millions)
Figure 84. Global Phage Therapy Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Phage Therapy Market Size Market Share Forecast by Application (2025-2030)
